| 证券代码：301017 | 证券简称：漱玉平民 | 公告编号：2025-115 | | --- | --- | --- | | 债券代码：123172 | 债券简称：漱玉转债 | | 漱玉平民大药房连锁股份有限公司 关于为全资子公司开展融资租赁业务提供担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或者重大遗漏。 一、担保情况概述 漱玉平民大药房连锁股份有限公司（以下简称"公司"）于 2025 年 1 月 21 日召开第 四届董事会第三次会议，于 2025 年 2 月 6 日召开 2025 年第一次临时股东大会，审议通过 了《关于 2025 年度公司及子公司向银行等机构申请综合授信额度及提供担保的议案》，同 意公司及子公司 2025 年度对合并报表范围内各级子公司提供的担保额度为人民币 167,011.00 万元。其中公司向全资子公司漱玉医药物流（山东）有限公司（以下简称"山 东物流"）提供不超过 60,000.00 万元的担保额度。担保额度有效期自 2025 年第一次临时 股东大会审议通过之日起十二个月。具体内容详见公司于 2025 年 1 月 22 ...

Group 1 - The pharmacy sector experienced a short-term decline, with stocks such as Shuyupingmin falling over 6% [1] - Other companies in the sector, including First Pharmaceutical, Dazhenglin, Yixintang, and Jianzhijia, also saw a drop in their stock prices [1]

Group 1 - The pharmacy sector has experienced a short-term decline, with major companies such as Xu Yu Ping Min falling over 6% [1] - Other companies in the sector, including First Pharmaceutical, Dazhenglin, Yixintang, and Jianzhijia, have also seen declines in their stock prices [1]

Investment Rating - The report maintains a "Neutral" rating for the pharmaceutical and biotechnology industry [1][42]. Core Insights - There is a recovery in demand for clinical research organizations (CROs), while the supply of experimental monkeys is tight, leading to price increases. The domestic financing for innovative drugs is gradually recovering, with a total financing amount of $4.086 billion from January to November 2025, representing a year-on-year increase of 10.6% [1][10]. - The pharmaceutical sector has underperformed compared to the CSI 300 index, with a year-to-date return of 14.49% against the CSI 300's 16.09% [22]. - The current valuation of the pharmaceutical sector is 33.0 times PE based on 2026 profit forecasts, which is a 41% premium over the overall A-share market (excluding financials) [23]. Summary by Sections Recent Trends - The CSI 300 index fell by 0.28% this week, while the pharmaceutical sector decreased by 0.14%, ranking 22nd among 31 primary sub-industries. The weekly performance of sub-sectors includes declines in chemical pharmaceuticals and biological products, while medical services and medical commerce showed gains [9][22]. Market Dynamics - The demand for CROs is recovering, and the supply of experimental monkeys is limited, with prices for 3-5 year old monkeys reaching 140,000 yuan each. This indicates a recovery in the domestic innovative drug research and development environment [10][11]. Valuation - The pharmaceutical sector's current valuation is 29.1 times PE based on trailing twelve months (TTM) earnings, which is below the historical average of 35.0 times PE. The sector has a 17.2% premium over the overall A-share market [23]. Company Performance - Notable performers in the pharmaceutical commercial sector this week include Huaren Health, Luyuan Pharmaceutical, and Shuyuan Pingmin, with significant weekly gains [25]. Key Company Meetings - Upcoming shareholder meetings include Dong'e Ejiao, Zhonghe Holdings, and Yiling Pharmaceutical on December 22, among others [31][32][33].

格隆汇12月19日丨漱玉平民(301017.SZ)公布，截至2025年12月18日，公司已通过集中竞价交易方式累 计出售回购股份2,988,788股，占公司总股本比例为0.7373%，出售所得资金总额为47,011,303.16元（不 含交易费用），成交最高价为16.77元/股，成交最低价为15.00元/股，成交均价为15.73元/股。 ...

格隆汇12月19日丨漱玉平民(301017.SZ)公布，截至2025年12月18日，公司已通过集中竞价交易方式累 计出售回购股份2,988,788股，占公司总股本比例为0.7373%，出售所得资金总额为47,011,303.16元（不 含交易费用），成交最高价为16.77元/股，成交最低价为15.00元/股，成交均价为15.73元/股。 ...

截至本公告日，本次出售计划已实施完毕。根据《深圳证券交易所上市公司自律监管 指引第 9 号——回购股份》等相关规定，上市公司采用集中竞价交易方式出售回购股份的， 出售计划实施完毕后，在两个交易日内披露出售结果暨股份变动公告。现将有关情况公告 如下： 一、公司已回购股份基本情况 | 证券代码：301017 | 证券简称：漱玉平民 | 公告编号：2025-114 | | --- | --- | --- | | 债券代码：123172 | 债券简称：漱玉转债 | | 漱玉平民大药房连锁股份有限公司 关于已回购股份出售结果暨股份变动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或者重大遗漏。 漱玉平民大药房连锁股份有限公司（以下简称"公司"）于 2025 年 11 月 18 日召开第 四届董事会第十三次会议审议通过了《关于出售 2024 年已回购股份的议案》，根据公司于 2024 年 2 月 22 日披露的《回购报告书》之用途约定，同意公司以集中竞价方式出售已回购 股份,实施期限为自该公告披露之日起 15 个交易日后的 6 个月内（即 2025 年 12 月 10 日至 ...

Market Overview - The A-share market experienced slight fluctuations today, with large-cap blue-chip stocks showing strength, as the Shanghai Composite Index and the Shanghai 50 Index slightly rose, while technology growth stocks faced adjustments, leading to small declines in the ChiNext Index, Sci-Tech 50, and North China 50. The market turnover reached 1.68 trillion yuan [1]. Index Performance - The Shenzhen Component Index closed at 13,053.97, down by 1.29% - The Shanghai Composite Index closed at 3,876.37, up by 0.16% - The ChiNext Index closed at 3,107.06, down by 2.17% - The Sci-Tech 50 Index closed at 1,305.97, down by 1.46% - The North China 50 Index closed at 1,431.71, down by 0.51% [2]. Sector Performance - Active sectors included pharmaceutical commerce, high-dividend stocks, elderly care concepts, and commercial aerospace, while sectors such as Hainan, consumer electronics, glass fiber, and power grid equipment saw the largest declines [2]. - Defense and military industry attracted over 9.5 billion yuan in net inflows, while banking received over 5.5 billion yuan. Other sectors like automotive and biopharmaceuticals also saw significant inflows exceeding 4 billion yuan [3]. Investment Insights - Huazhang Securities noted that historically, years of significant gains see increased volatility in January of the following year, suggesting a potential adjustment phase ahead. Investors are advised to remain patient and await clearer signals for upward trends. The AI industry is highlighted as a stable long-term investment focus [3]. - Guotai Junan emphasized that the spring market typically starts between December and April, with potential early initiation if prior market adjustments and favorable policy expectations align. Current market conditions present a crucial window for positioning in the spring rally [3]. High Dividend Stocks - High-dividend stocks saw a strong performance in the afternoon, with all bank stocks rising. Notable gainers included Shanghai Bank and Chongqing Rural Commercial Bank [4]. - The demand for stable cash flows from long-term funds like insurance and pension funds has increased significantly in a low-interest-rate environment. Insurance companies are projected to increase equity allocations by over 410 billion yuan in the first three quarters of 2025, with high-dividend assets comprising over half of the new positions [4]. Elderly Care Sector - The elderly care concept stocks were notably active, with companies like Jiayou Meikang and Waineng Health hitting their daily limit up of 20% [4]. - The National Health Commission has issued a plan to enhance elderly care services, aiming for a more comprehensive system by 2027 [5]. Silver Economy - The silver economy market in China is projected to reach 8.3 trillion yuan by 2024 and exceed 20 trillion yuan by 2030, with the consumption potential of the elderly population expected to grow to 106 trillion yuan by 2050, positioning China as a leader in the global silver economy market [6]. - CITIC Securities forecasts that the number of new pension recipients will increase by approximately 5.5 to 6 million annually over the next 2-3 years, which will be a significant driver for the silver economy and domestic demand expansion [6].

Market Performance - The ChiNext Index fell by 2.17%, closing at 3107.06 points, with a total trading volume of 449.855 billion yuan, a decrease of 45.259 billion yuan from the previous trading day [1] - Among the tradable ChiNext stocks, 730 stocks closed higher, with 10 stocks rising over 10%, including De Yi Culture, Shu Yu Ping Min, and Wan Long Optoelectronics, which hit the daily limit [1] - A total of 618 stocks closed lower, with 1 stock declining over 10% [1] Turnover Rate - The average turnover rate for the ChiNext today was 3.27%, with 24 stocks having a turnover rate exceeding 20% [1] - Stocks with the highest turnover rates included De Yi Culture at 39.21% and Tian Yin Machinery at 38.66% [1][2] Institutional Activity - Eight high turnover ChiNext stocks appeared on the Dragon and Tiger List, with institutional participation noted in several stocks [3] - De Yi Culture saw a net institutional buy of 72.3468 million yuan, while Tian Yin Machinery had a net buy of 51.0947 million yuan [3] Capital Flow - Among high turnover stocks, 18 experienced net inflows from main funds, with significant inflows into Hai Xia Innovation, Tian Yin Machinery, and Xi Ce Testing [4] - The stocks with the highest net inflows included Hai Xia Innovation at 488.5285 million yuan and Tian Yin Machinery at 405.2422 million yuan [4]

Market Overview - A total of 61 stocks hit the daily limit up, while 19 stocks faced limit down, resulting in a sealing rate of 76% [1] - The Shanghai Composite Index rose by 0.16%, while the Shenzhen Component Index and the ChiNext Index fell by 1.29% and 2.17% respectively [1] - The total trading volume in the Shanghai and Shenzhen markets was 1.66 trillion, a decrease of 155.7 billion from the previous trading day [1] Stock Performance - Baida Group achieved a six-day limit up streak, while Shengtong Energy and Pinao recorded five and four consecutive limit ups respectively [1][3] - The number of stocks advancing was nearly 2900, with notable performances in the pharmaceutical, banking, and retail sectors [1] - The commercial aerospace concept saw a resurgence, with stocks like Shunhao and Xibu Materials hitting limit up after previous declines [3][5] Sector Analysis - The pharmaceutical commercial sector experienced significant growth due to increased orders amid a rise in respiratory diseases during the winter season [14][15] - The retail sector, particularly driven by the "reward economy," showed strong performance with stocks like Baida Group and Nanjing Shanglv achieving consecutive limit ups [6][12] - The AI healthcare sector remained active, with Ant Group's AI health app "Antifortune" gaining popularity, leading to limit ups for companies like Meian Health and Huaren Health [7][19] Investment Themes - The commercial aerospace sector is highlighted as a strategic emerging industry, with government support and recent rocket launches boosting investor sentiment [5] - The "reward economy" is emerging as a new consumption model among younger demographics, contributing to the growth of related sectors [6][12] - The IP economy is gaining traction, with government initiatives aimed at promoting new consumption models and financial support for innovative businesses [16] Future Outlook - The market is expected to continue experiencing volatility, with a focus on small-cap stocks and growth sectors as larger stocks face profit-taking [9] - The Shanghai Composite Index is attempting to recover above key moving averages, indicating potential for further upward movement if trading volume increases [9]